Navigation Links
Tailored Clopidogrel Dosing Improves PCI Outcomes
Date:3/29/2008

Blood test monitors each patient's response to anti-clotting drug

CHICAGO, March 29 /PRNewswire/ -- Using a simple blood test to individualize the loading dose of a medication that prevents blood clotting significantly reduces the risk of major cardiovascular complications after percutaneous coronary interventions (PCI), according to a multicenter study reported today in a Late-Breaking Clinical Trials session at the SCAI Annual Scientific Sessions in Partnership with ACC i2 Summit (SCAI-ACCi2) in Chicago. SCAI-ACCi2 is a scientific meeting for practicing cardiovascular interventionalists sponsored by the Society for Cardiovascular Angiography and Interventions (SCAI) in partnership with the American College of Cardiology (ACC). The study will simultaneously publish in the Journal of the American College of Cardiology.

The study showed that in some patients, an initial, or loading, dose several times higher than usual is necessary to ensure the effectiveness of clopidogrel, a medication that prevents platelets from clumping together to form blood clots. The payoff for tailoring the clopidogrel dose: a significant reduction one month after PCI in the combined rates of heart attack, death, and need for repeat procedures to open the coronary arteries, with no increased risk of bleeding.

"Tailoring the loading dose of clopidogrel using platelet monitoring seems to be the best way to decrease the rate of major adverse cardiac events, in particular, stent thrombosis, which is the worst complication after PCI," said Laurent Bonello, MD, a cardiologist at Hopital Universitaire Nord, and Universite de la Mediterranee, both in Marseille, France.

Giving a large dose of clopidogrel before coronary stenting is standard procedure in cardiac catheterization laboratories. However, there is substantial variability among patients in the response to the anti-clotting drug. Previous studies have shown that a poor response to clopidogrel is linked to
'/>"/>

SOURCE SCAI-ACCi2
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Study Results Show Investigational Drug, Prasugrel, Cuts Risk of Stent-Related Clots by More than Half Versus Clopidogrel
2. Targanta Initiates Phase 2 Oritavancin Infrequent Dosing Study
3. New Phase III Data Presented for Once Monthly Dosing Regimen of Risedronate to Treat Postmenopausal Osteoporosis
4. DiObex Begins Dosing Patients in Phase 2b Trial of Type 2 Diabetes Drug
5. Pharmasset Commences Dosing in Phase 3 Registration Studies of Clevudine for HBV
6. Pharmasset Commences Dosing in 28-Day Combination Study of R7128 with Pegasys(R) plus Copegus(R) for Hepatitis C
7. Anthera Announces Completion of Enrollment and Dosing in Phase II Trial of A-002 for the Treatment of Cardiovascular Disease
8. Rockwell Medical Technologies, Inc. Begins Dosing Patients for SFP Phase IIb Clinical Study
9. Pivotal MIRCERA(R) Study First to Convert Dialysis Patients From Frequent Dosing Directly to Once Every Two Weeks or Once Every Four Weeks
10. Potent Hepatitis C Virus Inhibitors Show Efficacy and Potential for Once Daily Dosing in Preclinical Studies
11. Genta Completes Initial Clinical Dosing of G4544, a New Oral Drug for Bone Diseases
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/30/2014)... -- Nektar Therapeutics (Nasdaq: NKTR ) will announce ... 30, 2014 on Thursday, November 6, 2014, after the ... president and chief executive officer, will host a conference ... Eastern Time (ET)/2:00 p.m. Pacific Time (PT). ... of the conference call can be accessed through a ...
(Date:10/30/2014)... BOTHELL, Wash. , Oct. 30, 2014   ... a leading developer, manufacturer and marketer of proprietary clinical ... media and precision thermal shipping products ... Company,s third quarter 2014 financial results will be released ... will host a conference call and live webcast at ...
(Date:10/30/2014)... 30, 2014 Extensiv ... Aufbau von Kuhmilchverträglichkeit     Kuhmilchproteinallergie (KMPA) ... Säuglingen und Kleinkindern. Der bisher übliche Umgang ... der Babys bzw. deren stillenden Mütter Milchproteine ... sich bei einer beträchtlichen Anzahl von Kindern ...
Breaking Medicine Technology:Nektar to Announce Financial Results for the Third Quarter 2014 on Thursday, November 6, 2014, After Close of U.S.-Based Financial Markets 2BioLife Solutions to Report Financial Results for Third Quarter 2014 and Provide Business Update on November 6, 2014 2Experten präsentieren neuste Forschungsergebnisse auf dem Allergy Day 2Experten präsentieren neuste Forschungsergebnisse auf dem Allergy Day 3
... Pharmaceuticals, a specialty pharmaceutical company based in Atlanta, ... the company as General Counsel and Chief Compliance ... and most recently held positions of increasing responsibility ... at Shionogi, Leslie built the company,s legal department ...
... Mass., Feb. 21, 2012 UV Flu Technologies, Inc. ... in its 1st quarter report, filed on February 16, 2012, ... for the last 12 months, with another 20% reduction in ... sales and gross profits.  On February 3, 2012, the Company ...
Cached Medicine Technology:Leslie Zacks Joins Arbor Pharmaceuticals as General Counsel and Chief Compliance Officer 2UV Flu Technologies Continues Progress on Numerous Fronts 2UV Flu Technologies Continues Progress on Numerous Fronts 3
(Date:10/30/2014)... Horse Sense & Sensitivity ... special needs individuals in the Jacksonville area, will be ... from 10-2:00 p.m. at Bailey's Farm (2202 Bishop Estates ... public and is designed to raise awareness and funds ... HSS Round-Up is free. Ticket purchases will be required ...
(Date:10/30/2014)... 30, 2014 REV'D Provision Co. announced ... available through a unique service called, The Feed ... empower the everyday athlete. The Feed has taken the ... created a system to pass that information on to ... is now available on The Feed!” says REV’D® marketing ...
(Date:10/30/2014)... October 30, 2014 Victory Healthcare, ... its 2014 third quarter infection rates and patient ... infection rates of only two percent or less, ... scores exceeding 98 percent. , “We are delighted ... included rising satisfaction scores,” said Robert Helms, chairman ...
(Date:10/30/2014)... 29, 2014 (HealthDay News) -- Scientists who used stem ... say their breakthrough could provide a new way to ... diseases. The team used human pluripotent stem cells ... the body -- to grow the functional miniature stomachs, ... a major cause of ulcers and stomach cancer. ...
(Date:10/30/2014)... Oct. 29, 2014 (HealthDay News) -- Many U.S. ... campus, even though tanning increases the risk for ... among young adults, particularly white women, so colleges ... health, the researchers said. "Public health efforts ... population awareness of the harms that indoor tanning ...
Breaking Medicine News(10 mins):Health News:Horse Sense & Sensitivity, Jacksonville Non-profit, To Hold 2nd Annual Round-Up 2Health News:Nutrition Experts at TheFeed.com Get REV'D 2Health News:Nutrition Experts at TheFeed.com Get REV'D 3Health News:Victory Healthcare Releases Q3 Satisfaction, Infection Rates 2Health News:Victory Healthcare Releases Q3 Satisfaction, Infection Rates 3Health News:Many U.S. Colleges Have Indoor Tanning Salons On, Near Campus: Study 2
... WASHINGTON, Sept. 23 Speaker Nancy Pelosi delivered opening remarks ... Day Summit" this morning in the Capitol Visitor,s Center. Below are ... , "Thank you, Chairwoman Barbara Lee for your leadership ... , , "Essential to the CBC,s efforts ...
... , SAN FRANCISCO, Sept. 23 ... Convention to be held at the Santa Clara Marriot from ... Founded in 1998, FA is an international fellowship of individuals ... addiction. For many people who use food as a drug, ...
... release pills and capsules that show a tendency in the ... in a faster and potentially unsafe manner in patients who ... until proven safe with testing in people. That,s the ... issue of ACS, Molecular Pharmaceutics , a bi-monthly journal. ...
... , , WASHINGTON, Sept. 23 ... Americans are reporting stress attributed to financial concerns despite rising unemployment ... (APA). , , In a poll surveying ... 2009, 75 percent of adults reported that the economy caused stress ...
... , , PRINCETON, N.J., Sept. ... buy and carry condoms, the makers of Trojan(R) Brand Condoms recently ... and discreet plastic case. The new product, which is designed to ... the checkout counters of many food, drug and convenience retail locations, ...
... , NORTHRIDGE, Calif., Sept. 23 Today, Nature ... Your Greatness(TM) contest. Nature Made is the nation,s best-selling ... drug, mass and club channels. The company celebrates the inherent ... year, challenged Americans to submit their personal stories of greatness ...
Cached Medicine News:Health News:Pelosi Remarks at the Congressional Black Caucus Foundation's Annual Legislative Conference 2Health News:Pelosi Remarks at the Congressional Black Caucus Foundation's Annual Legislative Conference 3Health News:Food Addicts Convention Draws 800 Members from 31 States, 5 Nations Around the World 2Health News:Food Addicts Convention Draws 800 Members from 31 States, 5 Nations Around the World 3Health News:Interview Alert: At Anniversary of Financial Meltdown, Psychologists Notice Downward Trends in Economic Stress 2Health News:Makers of Trojan(R) Brand Condoms Introduce Trojan 2GO(R), a Unique, Portable, Protective and Discreet Packaging for Condoms 2Health News:Makers of Trojan(R) Brand Condoms Introduce Trojan 2GO(R), a Unique, Portable, Protective and Discreet Packaging for Condoms 3Health News:Makers of Trojan(R) Brand Condoms Introduce Trojan 2GO(R), a Unique, Portable, Protective and Discreet Packaging for Condoms 4Health News:National 'Greatness' Contest Winners Announced 2Health News:National 'Greatness' Contest Winners Announced 3
... Titanium Cranial Fixation Systems incorporate a ... requested by surgeons and surgical staff. ... may be either shaped on the ... a pre-measured, cut, bent and shaped ...
Specially designed combination of demineralized bone fibers and demineralized bone cubes that are both osteoinductive and osteoconductive. Packs well into bone defects. Eliminates the need to mix can...
... matrix and conductive cancellous chips. ... be free of foreign matter. ... is 125 to 1000 . ... 1 - 8 mm. 5:3 ...
Demineralized cortical fibers and cancellous chips....
Medicine Products: